Transcatheter pulmonary valve replacement is now a feasible alternative to surgical pulmonary valve replacement in children and adults with dysfunctional right ventricular outflow conduits. Currently, 2 types of valves can be used for this application. This article provides an overview of the procedure and how it is performed, indications and contraindications for transcatheter pulmonary valve replacement, and short- and long-term outcomes. Nursing considerations mainly focus on educating patients, preventing bleeding and infection, monitoring renal function, and preventing injury to the catheter insertion site. This article enhances the knowledge of nurses working in cardiac catheterization laboratories and post-procedure recovery and cardiac units so that the nurses can anticipate interventions and understand the management of patients who have transcatheter pulmonary valve replacement.
Skip Nav Destination
Feature| February 01 2018
Transcatheter Pulmonary Valve Replacement in Patients With Congenital Heart Disease
Shantelle Bartra, MSN, ARNP, PNP-PC
Shantelle Bartra is a pediatric nurse practitioner and coordinator in the cardiac catheterization laboratory, Congenital Heart Center, University of Florida Health, Shands Hospital, Gainesville, Florida.
Corresponding author: Shantelle Bartra, msn, arnp, pnp-pc, Congenital Heart Center, University of Florida, 1600 SW Archer Rd, PO Box 100297, Gainesville, FL 32610 (email: firstname.lastname@example.org).
Search for other works by this author on:
Crit Care Nurse (2018) 38 (1): 30–36.
Shantelle Bartra; Transcatheter Pulmonary Valve Replacement in Patients With Congenital Heart Disease. Crit Care Nurse 1 February 2018; 38 (1): 30–36. doi: https://doi.org/10.4037/ccn2018581
Download citation file:
Don't already have an account? Register
AACN AccountSign In
Sign in via your InstitutionSign in via your Institution
Subscribe online and gain access to the entire archive.
Purchase short-term access on a pay-per-article or pay-per-issue basis.
$15 72 - hour single article access $30 7 - day full issue access